News

CoramRx, an affiliate of Coram Specialty Infusion Services, provides national distribution and local services through specialty pharmacy facilities including more than 85 infusion pharmacies and 65 ambulatory infusion

Ponatinib is indicated for patients with resistant or intolerant chronic myeloid leukemia (CML) and Philadelphia-chromosome positive acute lymphoblastic leukemia (Ph+ ALL). Ariad chairman and CEO Harvey Berger said

According to the study, ALS-2200 was well-tolerated and there was a median 4.54 log10 reduction in hepatitis C virus (HCV) RNA in people with genotype 1 chronic hepatitis

The Levalbuterol Tartrate Inhalation Aerosol, a generic version of Sunovion Pharmaceuticals’ Xopenox HFA, is used to treat bronchospasm in adults, adolescents, 4 years children and older with reversible

Evaluation of Ponatinib versus Imatinib in Chronic Myeloid Leukemia (EPIC) trial of ponatinib will be conducted in newly diagnosed patients with chronic myeloid leukemia (CML). The trial will

The new assay will enable drug developers to test new drug candidates for interactions with BCRP, which is involved in drug clearance, resistance of tumors to anticancer drugs,

The recommended dose for both magnetic resonance imaging (MRI) of the central nervous system (CNS) and MRA examinations is 0.1mmol/kg (0.2ml/kg) of MultiHance. Bracco Diagnostics Group Medical and

Patent issuance comes as Neurotez completes GMP manufacturing of recombinant Leptin and prepares for IND-enabling studies. Preclinical in vitro data and in vivo and interventional studies, along with

The approval is based on positive findings from two global Phase 3 studies in which Kalydeco demonstrated significant improvements in breathing, weight gain and other measures of disease